Preview

谢切诺夫学报

高级搜索

ORGANIZATION OF PHARMACEUTICAL AID IN SOLVING THE PROBLEM OF EXCESS WEIGHT IN THE POPULATION

摘要

The article presents the system of organization of pharmaceutical aid to the population with excess body weight. The results of sociological surveys of the groups of applicants to the Health Center are shown, determining the socio-demographic characteristics of respondents, problems caused by excess body weight and motivation to its normalization, criteria of selection of drugs and other means to reduce the weight and the willingness of the population to acquire these means. Respondents were stratified according to body mass index, the first stratum - underweight (BMI 18.5), second stratum - normal (BMI of 18.5 -24.5), the third stratum having a need for correction of body weight (BMI 24.5 cm). The market of drugs and other means to reduce weight was analyzed. Physicians’ and pharmacists’ awareness of medicinal drugs and over-the-counter drugs used to reduce weight was studied by peer review method. Survey-based pharmaceutical workers identified Factors influencing the formation of demand for drugs and other means to reduce the weight (trademark, price, advertising, dosage form and convenience of self-administration, medical representative’s performance, personal experience). For each stratum of consumers a differentiated approach to the provision of pharmaceutical care was proposed including the provision of necessary medicines and other means, information and advisory assistance in the selection of the optimum tools for weight loss, a balanced diet and amount of physical activity.

关于作者

G. Ibragimova
Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University of the Ministry of Health of the Russian Federation
俄罗斯联邦


R. Khasanova
Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University of the Ministry of Health of the Russian Federation
俄罗斯联邦


参考

1. Бойцов С.А., Валегжанин С.В., Гилева Ф.А. и соавт. Совершенствование профилактики хронических неинфекционных заболеваний в учреждениях здравоохранения. Профилактическая медицина. 2013; 16(2): 3-12.

2. Ayyad C., Andersen T. Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999. Obes. Rev. 2000; 1(2): 113-119.

3. Obesity and overweight. WHO Fact sheet №311. Updated March 2013. Available at: http://www.who.int/mediacentre/ factsheets/fs311/en/. Accessed by: 15.04.2014. World Gastroenterology Organisation global guideline: obesity. Milwaukee (WI): World Gastroenterology Organisation (WGO); 2011.

4. Xu H., Barnes G. Yang Q., Tan G. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Investig. 2003; 112: 1821-1830.

5. Стрелкова С.Н., Овсянников К.В., Уткина Н.И. Роль немедикаментозных методов лечения метаболического синдрома: трудности и перспективы. Рациональная фармакотерапия в кардиологии. 2016; 12(6): 725-732.

6. Павленко О.А. Лечение ожирения в рамках всероссийской наблюдательной программы безопасного снижения веса «Примавера» в г. Томске. Эндокринология: новости, мнения, обучение. 2014; 3(8): 93-95.

7. Лескова И.В., Ермаков Д.М., Матушевская Е.Г. и соавт. Социально-медицинские аспекты нормализации массы тела. Ожирение и метаболизм. 2016; 13(4): 49-52.

8. Ибрагимова Г.Я., Хасанова Р.Ю. Маркетинговый анализ рынка лекарственных препаратов и других средств для снижения веса [электронный ресурс]. Вестник Башкирского государственного медицинского университета. 2015; 2. URL: https://vestnikbgmu.nethouse.ru/ static/000/000/056/701/doc/cc/cb/460b3923d17100ca165274 e22fdcb0d89c78.pdf (дата обращения: 21.10.2017).

9. Философский словарь [электронный ресурс]. URL: http://enc-dic.com/philosophy/Strata-3572 (дата обращения 13.09.2017).

10. Демидова Т.Ю., Стельмах М.В. Современные возможности и дальнейшие перспективы фармакотерапии ожирения. Терапия. 2016; 4(8): 24-33.

11. Об утверждении правил надлежащей аптечной практики лекарственных препаратов для медицинского применения. Приказ Министерства здравоохранения РФ № 647н от 31.08.2016.

12. Литвак Б.Г. Экспертные технологии в управлении. Дело. 2004; 400.

13. Литвак Б.Г. Экспертные оценки и принятие решений. М.: Патент, 1996: 271.

14. World Gastroenterology Organisation global guideline: obesity. Milwaukee (WI): World Gastroenterology Organisation (WGO); 2011


评论

浏览: 596


ISSN 2218-7332 (Print)
ISSN 2658-3348 (Online)